LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Science
• Education
• Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, google, scholar, pubmed, trail, cas, cells, apoptosis, esthesioneuroblastoma, cancer, bortezomib, walczak, tumor, koschny, primary, leipzig, human, sykora, ganten, cell, germany, apoptosisinducing, university, ahnert, access, neuroblastoma, res, haas, heidelberg, privacy, cookies, content, journal, research, sensitizes, trailinduced, holland, stremmel, ligand, combination, death, signaling, glioma, head, neck, clin, necrosis, factorrelated, sprick, caspase,

Topics {✒️}

apoptosis-resistant cholangiocarcinoma cells anticancer drug-induced apoptosis induces cancer-specific apoptosis month download article/chapter neuro-oncology aims bcl-xl overexpressing cells trail-induced apoptosis related subjects primary esthesioneuroblastoma cells anti-n-myc antibody anti-cancer therapy peter ahnert opipari aw jr trail-induced signalling full article pdf anti-tumor potential privacy choices/manage cookies cd95l-mediated apoptosis tumor cell proteasome inhibitor anti-cancer cytokine trail/bortezomib cotreatment check access comprehensive cancer center instant access author information authors electronic supplementary material n-myc expression apo2l/trail smac agonists sensitize european economic area long-term effect ß-phycoerythrin pi johnigan rh 3rd el-naggar ak cancer therapy interferon gamma renders membrane tr1/tr2 rainer baran-schmidt excellent technical assistance tumour genetics facial plastik surgery trail resistance article koschny trail promotes metastasis anti-apoptotic proteins conditions privacy policy aggressive tumor article journal proapoptotic receptor agonists

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis
         description:TNF-related apoptosis-inducing ligand (TRAIL), a promising novel anti-cancer cytokine of the TNF superfamily, and Bortezomib, the first-in-class clinically used proteasome inhibitor, alone or in combination have been shown to efficiently kill numerous tumor cell lines. However, data concerning primary human tumor cells are very rare. Using primary esthesioneuroblastoma cells we analyzed the anti-tumor potential and the mechanism employed by Bortezomib in combination with TRAIL for the treatment of this rare but aggressive tumor. Expression of components of the TRAIL pathway was analyzed in tumor specimens and isolated primary tumor cells at the protein level. Cells were treated with TRAIL, Bortezomib, and a combination thereof, and apoptosis induction was quantified. Clonogenicity assays were performed to elucidate the long-term effect of this treatment. Despite expressing all components of the TRAIL pathway, freshly isolated primary esthesioneuroblastoma cells were completely resistant to TRAIL-induced apoptosis. They could, however, be very efficiently sensitized by subtoxic doses of Bortezomib. The influence of Bortezomib on the TRAIL pathway was analyzed and showed upregulation of TRAIL death receptor expression, enhancement of the TRAIL death-inducing signaling complex (DISC), and downregulation of anti-apoptotic proteins of the TRAIL pathway. Of clinical relevance, TRAIL-resistant primary tumor cells could be repeatedly sensitized by Bortezomib, providing the basis for repeated clinical application schedules. This is the first report on the highly synergistic induction of apoptosis in primary esthesioneuroblastoma cells by Bortezomib and TRAIL. This combination, therefore, represents a promising novel therapeutic option for esthesioneuroblastoma.
         datePublished:2009-09-20T00:00:00Z
         dateModified:2009-09-20T00:00:00Z
         pageStart:171
         pageEnd:185
         sameAs:https://doi.org/10.1007/s11060-009-0010-6
         keywords:
            TRAIL
            Bortezomib
            Esthesioneuroblastoma
            Primary tumor cells
            Apoptosis
            Oncology
            Neurology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig1a-b_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig1c-d_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig1e-f_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig5_HTML.gif
         isPartOf:
            name:Journal of Neuro-Oncology
            issn:
               1573-7373
               0167-594X
            volumeNumber:97
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ronald Koschny
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Heidrun Holland
               affiliation:
                     name:University of Leipzig
                     address:
                        name:Translational Centre for Regenerative Medicine, Faculty of Medicine, University of Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jaromir Sykora
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ) Heidelberg
                     address:
                        name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hande Erdal
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wolfgang Krupp
               affiliation:
                     name:University of Leipzig
                     address:
                        name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Manfred Bauer
               affiliation:
                     name:University of Leipzig
                     address:
                        name:Institute of Neuropathology, University of Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ulrike Bockmuehl
               affiliation:
                     name:Head and Neck and Facial Plastik Surgery
                     address:
                        name:Department of Otorhinolaryngology, Head and Neck and Facial Plastik Surgery, Kassel, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Peter Ahnert
               affiliation:
                     name:University of Leipzig
                     address:
                        name:Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
                     name:University of Leipzig
                     address:
                        name:Institute for Clinical Immunology and Transfusion Medicine, and Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jürgen Meixensberger
               affiliation:
                     name:University of Leipzig
                     address:
                        name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wolfgang Stremmel
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Henning Walczak
               affiliation:
                     name:German Cancer Research Center (DKFZ) Heidelberg
                     address:
                        name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:Imperial College London
                     address:
                        name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tom M. Ganten
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis
      description:TNF-related apoptosis-inducing ligand (TRAIL), a promising novel anti-cancer cytokine of the TNF superfamily, and Bortezomib, the first-in-class clinically used proteasome inhibitor, alone or in combination have been shown to efficiently kill numerous tumor cell lines. However, data concerning primary human tumor cells are very rare. Using primary esthesioneuroblastoma cells we analyzed the anti-tumor potential and the mechanism employed by Bortezomib in combination with TRAIL for the treatment of this rare but aggressive tumor. Expression of components of the TRAIL pathway was analyzed in tumor specimens and isolated primary tumor cells at the protein level. Cells were treated with TRAIL, Bortezomib, and a combination thereof, and apoptosis induction was quantified. Clonogenicity assays were performed to elucidate the long-term effect of this treatment. Despite expressing all components of the TRAIL pathway, freshly isolated primary esthesioneuroblastoma cells were completely resistant to TRAIL-induced apoptosis. They could, however, be very efficiently sensitized by subtoxic doses of Bortezomib. The influence of Bortezomib on the TRAIL pathway was analyzed and showed upregulation of TRAIL death receptor expression, enhancement of the TRAIL death-inducing signaling complex (DISC), and downregulation of anti-apoptotic proteins of the TRAIL pathway. Of clinical relevance, TRAIL-resistant primary tumor cells could be repeatedly sensitized by Bortezomib, providing the basis for repeated clinical application schedules. This is the first report on the highly synergistic induction of apoptosis in primary esthesioneuroblastoma cells by Bortezomib and TRAIL. This combination, therefore, represents a promising novel therapeutic option for esthesioneuroblastoma.
      datePublished:2009-09-20T00:00:00Z
      dateModified:2009-09-20T00:00:00Z
      pageStart:171
      pageEnd:185
      sameAs:https://doi.org/10.1007/s11060-009-0010-6
      keywords:
         TRAIL
         Bortezomib
         Esthesioneuroblastoma
         Primary tumor cells
         Apoptosis
         Oncology
         Neurology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig1a-b_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig1c-d_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig1e-f_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_Fig5_HTML.gif
      isPartOf:
         name:Journal of Neuro-Oncology
         issn:
            1573-7373
            0167-594X
         volumeNumber:97
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ronald Koschny
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Heidrun Holland
            affiliation:
                  name:University of Leipzig
                  address:
                     name:Translational Centre for Regenerative Medicine, Faculty of Medicine, University of Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jaromir Sykora
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ) Heidelberg
                  address:
                     name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hande Erdal
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wolfgang Krupp
            affiliation:
                  name:University of Leipzig
                  address:
                     name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Manfred Bauer
            affiliation:
                  name:University of Leipzig
                  address:
                     name:Institute of Neuropathology, University of Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ulrike Bockmuehl
            affiliation:
                  name:Head and Neck and Facial Plastik Surgery
                  address:
                     name:Department of Otorhinolaryngology, Head and Neck and Facial Plastik Surgery, Kassel, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Peter Ahnert
            affiliation:
                  name:University of Leipzig
                  address:
                     name:Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
                  name:University of Leipzig
                  address:
                     name:Institute for Clinical Immunology and Transfusion Medicine, and Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jürgen Meixensberger
            affiliation:
                  name:University of Leipzig
                  address:
                     name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wolfgang Stremmel
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Henning Walczak
            affiliation:
                  name:German Cancer Research Center (DKFZ) Heidelberg
                  address:
                     name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:Imperial College London
                  address:
                     name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tom M. Ganten
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neuro-Oncology
      issn:
         1573-7373
         0167-594X
      volumeNumber:97
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Heidelberg
      address:
         name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:University of Leipzig
      address:
         name:Translational Centre for Regenerative Medicine, Faculty of Medicine, University of Leipzig, Leipzig, Germany
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ) Heidelberg
      address:
         name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:University of Leipzig
      address:
         name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
         type:PostalAddress
      name:University of Leipzig
      address:
         name:Institute of Neuropathology, University of Leipzig, Leipzig, Germany
         type:PostalAddress
      name:Head and Neck and Facial Plastik Surgery
      address:
         name:Department of Otorhinolaryngology, Head and Neck and Facial Plastik Surgery, Kassel, Germany
         type:PostalAddress
      name:University of Leipzig
      address:
         name:Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
         type:PostalAddress
      name:University of Leipzig
      address:
         name:Institute for Clinical Immunology and Transfusion Medicine, and Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany
         type:PostalAddress
      name:University of Leipzig
      address:
         name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ) Heidelberg
      address:
         name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:Imperial College London
      address:
         name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ronald Koschny
      affiliation:
            name:University of Heidelberg
            address:
               name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Heidrun Holland
      affiliation:
            name:University of Leipzig
            address:
               name:Translational Centre for Regenerative Medicine, Faculty of Medicine, University of Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
      name:Jaromir Sykora
      affiliation:
            name:University of Heidelberg
            address:
               name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ) Heidelberg
            address:
               name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Hande Erdal
      affiliation:
            name:University of Heidelberg
            address:
               name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Wolfgang Krupp
      affiliation:
            name:University of Leipzig
            address:
               name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
      name:Manfred Bauer
      affiliation:
            name:University of Leipzig
            address:
               name:Institute of Neuropathology, University of Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
      name:Ulrike Bockmuehl
      affiliation:
            name:Head and Neck and Facial Plastik Surgery
            address:
               name:Department of Otorhinolaryngology, Head and Neck and Facial Plastik Surgery, Kassel, Germany
               type:PostalAddress
            type:Organization
      name:Peter Ahnert
      affiliation:
            name:University of Leipzig
            address:
               name:Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
            name:University of Leipzig
            address:
               name:Institute for Clinical Immunology and Transfusion Medicine, and Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
      name:Jürgen Meixensberger
      affiliation:
            name:University of Leipzig
            address:
               name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
               type:PostalAddress
            type:Organization
      name:Wolfgang Stremmel
      affiliation:
            name:University of Heidelberg
            address:
               name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Henning Walczak
      affiliation:
            name:German Cancer Research Center (DKFZ) Heidelberg
            address:
               name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:Imperial College London
            address:
               name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
               type:PostalAddress
            type:Organization
      name:Tom M. Ganten
      affiliation:
            name:University of Heidelberg
            address:
               name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
      name:Translational Centre for Regenerative Medicine, Faculty of Medicine, University of Leipzig, Leipzig, Germany
      name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
      name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
      name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
      name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
      name:Institute of Neuropathology, University of Leipzig, Leipzig, Germany
      name:Department of Otorhinolaryngology, Head and Neck and Facial Plastik Surgery, Kassel, Germany
      name:Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
      name:Institute for Clinical Immunology and Transfusion Medicine, and Center for Biotechnology and Biomedicine, University of Leipzig, Leipzig, Germany
      name:Clinic of Neurosurgery, University of Leipzig, Leipzig, Germany
      name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
      name:Division of Apoptosis Regulation (D040), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany
      name:Tumour Immunology Unit, Division of Medicine, Imperial College London, London, UK
      name:Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(141)

• Discover the revenue of https://www.springernature.com/gp/authors
• https://link.springernature.com/home/ income
• Explore the financials of https://order.springer.com/public/cart
• How much profit does https://submission.nature.com/new-submission/11060/3 make?
• What is the monthly revenue of https://www.springernature.com/gp/librarians/licensing/agc/journals?
• What is the earnings of https://doi.org/10.1002%2Fhed.20127?
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15654688
• What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Olfactory%20neuroblastoma%3A%20the%2022-year%20experience%20at%20one%20comprehensive%20cancer%20center&journal=Head%20Neck&doi=10.1002%2Fhed.20127&volume=27&pages=138-149&publication_year=2005&author=Diaz%2CEM&author=Johnigan%2CRH&author=Pero%2CC&author=El-Naggar%2CAK&author=Roberts%2CDB&author=Barker%2CJL&author=DeMonte%2CF?
• What's the revenue for https://doi.org/10.1097%2F00020840-200304000-00009?
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14515089
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Diagnosis%20and%20management%20of%20esthesioneuroblastoma&journal=Curr%20Opin%20Otolaryngol%20Head%20Neck%20Surg&doi=10.1097%2F00020840-200304000-00009&volume=11&pages=112-118&publication_year=2003&author=Bradley%2CPJ&author=Jones%2CNS&author=Robertson%2CI have monthly?
• http://scholar.google.com/scholar_lookup?&title=Management%20of%20intracranial%20invasive%20olfactory%20neuroblastoma&journal=Chin%20Med%20J%20%28Engl%29&volume=120&pages=224-227&publication_year=2007&author=Zhang%2CLW&author=Zhang%2CMS&author=Qi%2CJ&author=Zhang%2CJT&author=Li%2CGL&author=Luo%2CL&author=Wang%2CZC's total income per month
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17491347
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Olfactory%20neuroblastoma%20with%20spinal%20metastasis%3A%20case%20report&journal=No%20Shinkei%20Geka&volume=35&pages=503-508&publication_year=2007&author=Mori%2CR&author=Sakai%2CH&author=Kato%2CM&author=Hida%2CT&author=Nakajima%2CM&author=Fukuda%2CT&author=Fukunaga%2CM&author=Abe%2CT?
• Discover the revenue of https://doi.org/10.1227%2F00006123-199305000-00002
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8492845
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Esthesioneuroblastoma%3A%20prognosis%20and%20management&journal=Neurosurgery&doi=10.1227%2F00006123-199305000-00002&volume=32&pages=706-714&publication_year=1993&author=Morita%2CA&author=Ebersold%2CMJ&author=Olsen%2CKD&author=Foote%2CRL&author=Lewis%2CJE&author=Quast%2CLM
• What's https://doi.org/10.1002%2Fhed.20920's gross income?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18798301 pull in monthly?
• http://scholar.google.com/scholar_lookup?&title=Esthesioneuroblastoma%3A%20the%20Princess%20Margaret%20hospital%20experience&journal=Head%20Neck&doi=10.1002%2Fhed.20920&volume=30&pages=1607-1614&publication_year=2008&author=Bachar%2CG&author=Goldstein%2CDP&author=Shah%2CM&author=Tandon%2CA&author=Ringash%2CJ&author=Pond%2CG&author=Gullane%2CPJ&author=Perez-Ordonez%2CB&author=Gilbert%2CRW&author=Brown%2CDH&author=Gentili%2CF&author=O%E2%80%99Sullivan%2CB&author=Irish%2CJC's financial summary
• https://doi.org/10.1016%2FS1470-2045%2801%2900558-7's total income per month
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11902539?
• Get to know http://scholar.google.com/scholar_lookup?&title=Esthesioneuroblastoma%3A%20a%20meta-analysis%20and%20review&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2801%2900558-7&volume=2&pages=683-690&publication_year=2001&author=Dulguerov%2CP&author=Allal%2CAS&author=Calcaterra%2CTC's earnings
• How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18633576 make?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Retrospective%20review%20of%20adjuvant%20chemotherapy%20for%20esthesioneuroblastoma&journal=J%20Neurooncol&doi=10.1007%2Fs11060-008-9645-y&volume=90&pages=201-204&publication_year=2008&author=Porter%2CAB&author=Bernold%2CDM&author=Giannini%2CC&author=Foote%2CRL&author=Link%2CMJ&author=Olsen%2CKD&author=Moynihan%2CTJ&author=Buckner%2CJC
• How much does https://doi.org/10.1006%2Fexcr.2000.4840 gross monthly?
• Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10739652
• How much does http://scholar.google.com/scholar_lookup?&title=The%20CD95%20%28APO-1%2FFas%29%20and%20the%20TRAIL%20%28APO-2L%29%20apoptosis%20systems&journal=Exp%20Cell%20Res&doi=10.1006%2Fexcr.2000.4840&volume=256&pages=58-66&publication_year=2000&author=Walczak%2CH&author=Krammer%2CPH pull in?
• Find out how much https://doi.org/10.1016%2FS0378-4274%2802%2900422-8 earns monthly
• Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12628743 is on a monthly basis
• How much money does http://scholar.google.com/scholar_lookup?&title=TRAIL-induced%20signalling%20and%20apoptosis&journal=Toxicol%20Lett&doi=10.1016%2FS0378-4274%2802%2900422-8&volume=139&pages=89-97&publication_year=2003&author=MacFarlane%2CM make?
• Discover the revenue of https://doi.org/10.2174%2F157488709787047530
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19149761?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=TRAIL%20agonists%20on%20clinical%20trials%20for%20cancer%20therapy%3A%20the%20promises%20and%20the%20challenges&journal=Rev%20Recent%20Clin%20Trials&doi=10.2174%2F157488709787047530&volume=4&pages=34-41&publication_year=2009&author=Bellail%2CAC&author=Qi%2CL&author=Mulligan%2CP&author=Chhabra%2CV&author=Hao%2CC
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17437073 have monthly?
• What's http://scholar.google.com/scholar_lookup?&title=The%20promise%20of%20TRAIL-potential%20and%20risks%20of%20a%20novel%20anticancer%20therapy&journal=J%20Mol%20Med&doi=10.1007%2Fs00109-007-0194-1&volume=85&pages=923-935&publication_year=2007&author=Koschny%2CR&author=Walczak%2CH&author=Ganten%2CTM's gross income?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12118245 generate?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Smac%20agonists%20sensitize%20for%20Apo2L%2FTRAIL-%20or%20anticancer%20drug-induced%20apoptosis%20and%20induce%20regression%20of%20malignant%20glioma%20in%20vivo&journal=Nat%20Med&volume=8&pages=808-815&publication_year=2002&author=Fulda%2CS&author=Wick%2CW&author=Weller%2CM&author=Debatin%2CKM
• What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11350907?
• How much does http://scholar.google.com/scholar_lookup?&title=Direct%20stimulation%20of%20apoptotic%20signaling%20by%20soluble%20apo2l%2Ftumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20leads%20to%20selective%20killing%20of%20glioma%20cells&journal=Clin%20Cancer%20Res&volume=7&pages=1362-1369&publication_year=2001&author=Pollack%2CIF&author=Erff%2CM&author=Ashkenazi%2CA bring in each month?
• How much revenue does https://doi.org/10.1158%2F1078-0432.CCR-07-0251 bring in?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17545549?
• How much money does http://scholar.google.com/scholar_lookup?&title=Bortezomib%20sensitizes%20primary%20human%20astrocytoma%20cells%20of%20WHO%20grades%20I%20to%20IV%20for%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand-induced%20apoptosis&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-07-0251&volume=13&pages=3403-3412&publication_year=2007&author=Koschny%2CR&author=Holland%2CH&author=Sykora%2CJ&author=Haas%2CTL&author=Sprick%2CMR&author=Ganten%2CTM&author=Krupp%2CW&author=Bauer%2CM&author=Ahnert%2CP&author=Meixensberger%2CJ&author=Walczak%2CH generate?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18771087 earns monthly
• Earnings of http://scholar.google.com/scholar_lookup?&title=Bortezomib%20as%20a%20therapeutic%20candidate%20for%20neuroblastoma&journal=J%20Exp%20Ther%20Oncol&volume=7&pages=135-145&publication_year=2008&author=Armstrong%2CMB&author=Schumacher%2CKR&author=Mody%2CR&author=Yanik%2CGA&author=Opipari%2CAW&author=Castle%2CVP
• What's https://doi.org/10.1002%2Fhep.21555's gross income?
• Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17326159 earns monthly
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=TRAIL%2Fbortezomib%20cotreatment%20is%20potentially%20hepatotoxic%20but%20induces%20cancer-specific%20apoptosis%20within%20a%20therapeutic%20window&journal=Hepatology&doi=10.1002%2Fhep.21555&volume=45&pages=649-658&publication_year=2007&author=Koschny%2CR&author=Ganten%2CTM&author=Sykora%2CJ&author=Haas%2CTL&author=Sprick%2CMR&author=Kolb%2CA&author=Stremmel%2CW&author=Walczak%2CH?
• Earnings of https://doi.org/10.1002%2Fhep.20807
• What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16037944?
• How much does http://scholar.google.com/scholar_lookup?&title=Proteasome%20inhibition%20sensitizes%20hepatocellular%20carcinoma%20cells%2C%20but%20not%20human%20hepatocytes%2C%20to%20TRAIL&journal=Hepatology&doi=10.1002%2Fhep.20807&volume=42&pages=588-597&publication_year=2005&author=Ganten%2CTM&author=Koschny%2CR&author=Haas%2CTL&author=Sykora%2CJ&author=Li-Weber%2CM&author=Herzer%2CK&author=Walczak%2CH earn?
• How much does https://doi.org/10.1016%2Fj.cancergencyto.2006.09.024 earn?
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17321323 income
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Comprehensive%20cytogenetic%20characterization%20of%20an%20esthesioneuroblastoma&journal=Cancer%20Genet%20Cytogenet&doi=10.1016%2Fj.cancergencyto.2006.09.024&volume=173&pages=89-96&publication_year=2007&author=Holland%2CH&author=Koschny%2CR&author=Krupp%2CW&author=Meixensberger%2CJ&author=Bauer%2CM&author=Kirsten%2CH&author=Ahnert%2CP?
• What's the monthly income of https://doi.org/10.1158%2F1078-0432.CCR-05-2635?
• What's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16638878?
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Preclinical%20differentiation%20between%20apparently%20safe%20and%20potentially%20hepatotoxic%20applications%20of%20TRAIL%20either%20alone%20or%20in%20combination%20with%20chemotherapeutic%20drugs&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-05-2635&volume=12&pages=2640-2646&publication_year=2006&author=Ganten%2CTM&author=Koschny%2CR&author=Sykora%2CJ&author=Schulze-Bergkamen%2CH&author=Buchler%2CP&author=Haas%2CTL&author=Schader%2CMB&author=Untergasser%2CA&author=Stremmel%2CW&author=Walczak%2CH
• What are the total earnings of https://doi.org/10.1038%2Fsj.cdd.4401437?
• What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15105837?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Enhanced%20caspase-8%20recruitment%20to%20and%20activation%20at%20the%20DISC%20is%20critical%20for%20sensitisation%20of%20human%20hepatocellular%20carcinoma%20cells%20to%20TRAIL-induced%20apoptosis%20by%20chemotherapeutic%20drugs&journal=Cell%20Death%20Differ&doi=10.1038%2Fsj.cdd.4401437&volume=11&issue=Suppl%201&pages=S86-S96&publication_year=2004&author=Ganten%2CTM&author=Haas%2CTL&author=Sykora%2CJ&author=Stahl%2CH&author=Sprick%2CMR&author=Fas%2CSC&author=Krueger%2CA&author=Weigand%2CMA&author=Grosse-Wilde%2CA&author=Stremmel%2CW&author=Krammer%2CPH&author=Walczak%2CH
• https://doi.org/10.1016%2FS1074-7613%2800%2980211-3's total income per month
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10894160 produce monthly?
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=FADD%2FMORT1%20and%20caspase-8%20are%20recruited%20to%20TRAIL%20receptors%201%20and%202%20and%20are%20essential%20for%20apoptosis%20mediated%20by%20TRAIL%20receptor%202&journal=Immunity&doi=10.1016%2FS1074-7613%2800%2980211-3&volume=12&pages=599-609&publication_year=2000&author=Sprick%2CMR&author=Weigand%2CMA&author=Rieser%2CE&author=Rauch%2CCT&author=Juo%2CP&author=Blenis%2CJ&author=Krammer%2CPH&author=Walczak%2CH?
• Income figures for https://doi.org/10.1016%2FS0304-3835%2802%2900020-4
• How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12175541 have monthly?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20N-myc%20expression%20in%20development%20and%20disease&journal=Cancer%20Lett&doi=10.1016%2FS0304-3835%2802%2900020-4&volume=180&pages=107-119&publication_year=2002&author=Strieder%2CV&author=Lutz%2CW each month?
• What's the revenue for https://doi.org/10.1097%2F00043426-199121000-00027?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2029081?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Cytogenetic%20and%20molecular%20evaluation%20of%20clinically%20aggressive%20esthesioneuroblastoma&journal=Am%20J%20Pediatr%20Hematol%20Oncol&doi=10.1097%2F00043426-199121000-00027&volume=13&pages=62-70&publication_year=1991&author=Castaneda%2CVL&author=Cheah%2CMS&author=Saldivar%2CVA&author=Richmond%2CCM&author=Parmley%2CRT?
• How much does https://doi.org/10.1074%2Fjbc.M202946200 generate monthly?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11976344
• http://scholar.google.com/scholar_lookup?&title=Tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand-induced%20death-%20inducing%20signaling%20complex%20and%20its%20modulation%20by%20c-FLIP%20and%20PED%2FPEA-15%20in%20glioma%20cells&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M202946200&volume=277&pages=25020-25025&publication_year=2002&author=Xiao%2CC&author=Yang%2CBF&author=Asadi%2CN&author=Beguinot%2CF&author=Hao%2CC's revenue stream
• How much money does https://doi.org/10.1172%2FJCI34359 make?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18523647 bring in each month?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=To%20kill%20a%20tumor%20cell%3A%20the%20potential%20of%20proapoptotic%20receptor%20agonists&journal=J%20Clin%20Invest&doi=10.1172%2FJCI34359&volume=118&pages=1979-1990&publication_year=2008&author=Ashkenazi%2CA&author=Herbst%2CRS?
• What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12615731?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Induction%20of%20caspase%208%20by%20interferon%20gamma%20renders%20some%20neuroblastoma%20%28NB%29%20cells%20sensitive%20to%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20but%20reveals%20that%20a%20lack%20of%20membrane%20TR1%2FTR2%20also%20contributes%20to%20TRAIL%20resistance%20in%20NB&journal=Cancer%20Res&volume=63&pages=1122-1129&publication_year=2003&author=Yang%2CX&author=Merchant%2CMS&author=Romero%2CME&author=Tsokos%2CM&author=Wexler%2CLH&author=Kontny%2CU&author=Mackall%2CCL&author=Thiele%2CCJ have monthly?
• Discover the revenue of https://doi.org/10.1002%2Fcncr.21323
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16080161
• How much does http://scholar.google.com/scholar_lookup?&title=Caspase%208%20is%20absent%20or%20low%20in%20many%20ex%20vivo%20gliomas&journal=Cancer&doi=10.1002%2Fcncr.21323&volume=104&pages=1487-1496&publication_year=2005&author=Ashley%2CDM&author=Riffkin%2CCD&author=Muscat%2CAM&author=Knight%2CMJ&author=Kaye%2CAH&author=Novak%2CU&author=Hawkins%2CCJ generate monthly?
• How much profit is https://doi.org/10.1152%2Fajpgi.00242.2005 making per month?
• What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16166346?
• What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Trail%20induces%20cell%20migration%20and%20invasion%20in%20apoptosis-resistant%20cholangiocarcinoma%20cells&journal=Am%20J%20Physiol%20Gastrointest%20Liver%20Physiol&doi=10.1152%2Fajpgi.00242.2005&volume=290&pages=G129-G136&publication_year=2006&author=Ishimura%2CN&author=Isomoto%2CH&author=Bronk%2CSF&author=Gores%2CGJ?
• How much income does https://doi.org/10.1038%2Fsj.onc.1209719 have?
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16751802?
• How much does http://scholar.google.com/scholar_lookup?&title=TRAIL%20promotes%20metastasis%20of%20human%20pancreatic%20ductal%20adenocarcinoma&journal=Oncogene&doi=10.1038%2Fsj.onc.1209719&volume=25&pages=7434-7439&publication_year=2006&author=Trauzold%2CA&author=Siegmund%2CD&author=Schniewind%2CB&author=Sipos%2CB&author=Egberts%2CJ&author=Zorenkov%2CD&author=Emme%2CD&author=Roder%2CC&author=Kalthoff%2CH&author=Wajant%2CH pull in?
• How much income does https://doi.org/10.1038%2Fsj.onc.1206656 have?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12902978?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=The%20proteasome%20inhibitor%20PS-341%20overcomes%20TRAIL%20resistance%20in%20Bax%20and%20caspase%209-negative%20or%20Bcl-xL%20overexpressing%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1206656&volume=22&pages=4953-4963&publication_year=2003&author=Johnson%2CTR&author=Stone%2CK&author=Nikrad%2CM&author=Yeh%2CT&author=Zong%2CWX&author=Thompson%2CCB&author=Nesterov%2CA&author=Kraft%2CAS?
• Find out how much https://doi.org/10.1038%2Fsj.onc.1210985 earns monthly
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18084329 net monthly?
• Learn how profitable http://scholar.google.com/scholar_lookup?&title=Suppression%20of%20cFLIP%20is%20sufficient%20to%20sensitize%20human%20melanoma%20cells%20to%20TRAIL-%20and%20CD95L-mediated%20apoptosis&journal=Oncogene&doi=10.1038%2Fsj.onc.1210985&volume=27&pages=3211-3220&publication_year=2008&author=Geserick%2CP&author=Drewniok%2CC&author=Hupe%2CM&author=Haas%2CTL&author=Diessenbacher%2CP&author=Sprick%2CMR&author=Schon%2CMP&author=Henkler%2CF&author=Gollnick%2CH&author=Walczak%2CH&author=Leverkus%2CM is on a monthly basis
• Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11221847
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Induction%20and%20intracellular%20regulation%20of%20tumor%20necrosis%20factor-related%20apoptosis-inducing%20ligand%20%28TRAIL%29%20mediated%20apotosis%20in%20human%20malignant%20glioma%20cells&journal=Cancer%20Res&volume=61&pages=1162-1170&publication_year=2001&author=Hao%2CC&author=Beguinot%2CF&author=Condorelli%2CG&author=Trencia%2CA&author=Meir%2CEG&author=Yong%2CVW&author=Parney%2CIF&author=Roa%2CWH&author=Petruk%2CKC
• What's the financial gain of https://doi.org/10.1016%2Fj.otohns.2008.03.011?
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18984268's gross income?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20Bcl-2%20in%20olfactory%20neuroblastoma%20and%20its%20association%20with%20chemotherapy%20and%20survival&journal=Otolaryngol%20Head%20Neck%20Surg&doi=10.1016%2Fj.otohns.2008.03.011&volume=139&pages=708-712&publication_year=2008&author=Kim%2CJW&author=Kong%2CIG&author=Lee%2CCH&author=Kim%2CDY&author=Rhee%2CCS&author=Min%2CYG&author=Kim%2CCW&author=Chung%2CJH generate?
• Get to know what's the income of https://citation-needed.springer.com/v2/references/10.1007/s11060-009-0010-6?format=refman&flavour=references
• How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ronald%20Koschny bring in?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ronald%20Koschny%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
• Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Heidrun%20Holland
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Heidrun%20Holland%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jaromir%20Sykora
• What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jaromir%20Sykora%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hande%20Erdal net monthly?
• What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hande%20Erdal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wolfgang%20Krupp
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wolfgang%20Krupp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Manfred%20Bauer making per month?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Manfred%20Bauer%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ulrike%20Bockmuehl earning monthly?
• Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ulrike%20Bockmuehl%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Peter%20Ahnert net monthly?
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Peter%20Ahnert%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=J%C3%BCrgen%20Meixensberger?
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22J%C3%BCrgen%20Meixensberger%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wolfgang%20Stremmel?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wolfgang%20Stremmel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
• What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Henning%20Walczak?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Henning%20Walczak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What is the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tom%20M.%20Ganten?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tom%20M.%20Ganten%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the monthly income of https://static-content.springer.com/esm/art%3A10.1007%2Fs11060-009-0010-6/MediaObjects/11060_2009_10_MOESM1_ESM.pdf?
• How much income does https://s100.copyright.com/AppDispatchServlet?title=Bortezomib%20sensitizes%20primary%20human%20esthesioneuroblastoma%20cells%20to%20TRAIL-induced%20apoptosis&author=Ronald%20Koschny%20et%20al&contentID=10.1007%2Fs11060-009-0010-6©right=Springer%20Science%2BBusiness%20Media%2C%20LLC.&publication=0167-594X&publicationDate=2009-09-20&publisherName=SpringerNature&orderBeanReset=true have?
• Financial intake of https://citation-needed.springer.com/v2/references/10.1007/s11060-009-0010-6?format=refman&flavour=citation
• How much revenue does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral bring in?
• How much income is https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research earning monthly?
• Find out how much https://www.springernature.com/gp/products earns monthly
• What are the earnings of https://www.springernature.com/gp/librarians?
• Find out how much https://www.springernature.com/gp/societies earns monthly
• Revenue of https://www.springernature.com/gp/partners
• Find out how much https://www.springer.com/ earns monthly
• How much revenue does https://www.nature.com/ produce monthly?
• How much revenue does https://www.biomedcentral.com/ produce monthly?
• What's the monthly income of https://www.palgrave.com/?
• How profitable is https://www.apress.com/?
• What are the total earnings of https://www.springernature.com/gp/legal/ccpa?
• Learn about the earnings of https://www.springernature.com/gp/info/accessibility
• What's the income of https://support.springernature.com/en/support/home?
• Income figures for https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
• What's the financial outcome of https://www.springernature.com/?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

CDN Services {📦}

• Crossref